statistiche ricercatore

MORTARA, LORENZO

Distribuzione geografica

Continente	#
NA - Nord America	17.214
EU - Europa	14.648
AS - Asia	7.620
SA - Sud America	774
Continente sconosciuto - Info sul continente non disponibili	345
AF - Africa	147
OC - Oceania	29
AN - Antartide	1
Totale	40.778

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	16.888
IT - Italia	8.406
SG - Singapore	2.494
UA - Ucraina	1.796
CN - Cina	1.707
VN - Vietnam	1.081
HK - Hong Kong	844
TR - Turchia	812
SE - Svezia	724
FR - Francia	697
DE - Germania	679
BR - Brasile	647
FI - Finlandia	615
IE - Irlanda	488
GB - Regno Unito	377
RU - Federazione Russa	275
IN - India	180
BD - Bangladesh	166
CA - Canada	150
NL - Olanda	140
MX - Messico	117
JP - Giappone	93
ES - Italia	77
PL - Polonia	77
AR - Argentina	54
BE - Belgio	49
CH - Svizzera	46
IQ - Iraq	45
AT - Austria	42
ZA - Sudafrica	41
NG - Nigeria	40
CZ - Repubblica Ceca	31
PK - Pakistan	25
ID - Indonesia	20
LT - Lituania	20
MY - Malesia	20
EC - Ecuador	18
PT - Portogallo	18
AU - Australia	17
AE - Emirati Arabi Uniti	15
UZ - Uzbekistan	15
EU - Europa	14
SA - Arabia Saudita	14
CL - Cile	13
CO - Colombia	13
EG - Egitto	13
MA - Marocco	13
NZ - Nuova Zelanda	12
RO - Romania	12
MD - Moldavia	11
VE - Venezuela	11
CR - Costa Rica	10
NO - Norvegia	10
PY - Paraguay	10
IL - Israele	9
TH - Thailandia	9
DZ - Algeria	8
GR - Grecia	8
HN - Honduras	8
JM - Giamaica	8
KE - Kenya	8
PH - Filippine	8
TN - Tunisia	8
BG - Bulgaria	7
JO - Giordania	7
KR - Corea	7
KZ - Kazakistan	6
NP - Nepal	6
BH - Bahrain	5
HU - Ungheria	5
LB - Libano	5
NI - Nicaragua	5
OM - Oman	5
SN - Senegal	5
TT - Trinidad e Tobago	5
AZ - Azerbaigian	4
BB - Barbados	4
BY - Bielorussia	4
EE - Estonia	4
RS - Serbia	4
DK - Danimarca	3
DO - Repubblica Dominicana	3
IR - Iran	3
LU - Lussemburgo	3
MK - Macedonia	3
PE - Perù	3
PR - Porto Rico	3
PS - Palestinian Territory	3
SK - Slovacchia (Repubblica Slovacca)	3
UY - Uruguay	3
A2 - ???statistics.table.value.countryCode.A2???	2
AL - Albania	2
BA - Bosnia-Erzegovina	2
BF - Burkina Faso	2
CG - Congo	2
DM - Dominica	2
GT - Guatemala	2
MC - Monaco	2
ML - Mali	2
MT - Malta	2
Totale	40.414

Salva come PNG Salva come JPEG

Città	#
Milan	4.303
San Jose	1.654
Singapore	1.439
Jacksonville	1.342
Chandler	1.254
Ashburn	1.241
Fairfield	1.025
Hong Kong	824
Woodbridge	773
Ann Arbor	629
Council Bluffs	622
Houston	545
Dallas	510
Princeton	492
Beijing	490
Dublin	481
Wilmington	461
Rome	425
Dearborn	421
Izmir	400
Nyköping	379
The Dalles	379
Seattle	363
Boardman	358
Como	343
Cambridge	317
Dong Ket	314
Lauterbourg	251
Los Angeles	251
Chicago	249
New York	232
San Mateo	162
Ho Chi Minh City	160
Helsinki	146
Hanoi	145
Santa Clara	122
Munich	103
San Diego	101
Kocaeli	93
London	92
Ogden	84
Tokyo	77
Orem	75
Turin	75
Mexico City	74
São Paulo	73
Guangzhou	71
Varese	65
Buffalo	61
Turku	60
Warsaw	58
Chennai	55
Frankfurt am Main	53
Florence	52
Hefei	52
Verona	50
Düsseldorf	49
Brussels	43
Manchester	43
Kunming	42
Montreal	41
Nanjing	40
Stockholm	40
Brooklyn	39
Denver	38
Genoa	38
Atlanta	36
Toronto	36
Washington	36
San Francisco	35
Shanghai	35
Bologna	34
Phoenix	34
Jinan	32
Johannesburg	32
Amsterdam	31
Abuja	30
Boston	30
Norwalk	29
Salt Lake City	28
Nuremberg	26
Poplar	26
Bari	25
Da Nang	25
Pune	25
Hangzhou	24
Palermo	24
Vienna	24
Brno	23
Berlin	22
Tianjin	21
Fuzhou	20
Naples	20
Querétaro	20
Redmond	20
Des Moines	19
Zhengzhou	19
Brescia	18
Haiphong	18
Baghdad	17
Totale	26.233

Salva come PNG Salva come JPEG

Nome	#
Allergie e intolleranze. Icone di immunopatologia.	2.736
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC	308
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer	306
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype	285
Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression	271
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?	256
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	247
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies	244
Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?	243
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization	235
Grading of laboratories on CD4+T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error	229
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response	229
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy	226
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS	226
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype	226
Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects	225
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways	223
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	223
DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm	219
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions.	218
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer	216
Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons.	215
Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period.	214
T2 ribonuclease-mediated tumor suppression: an evolutionary conserved process involving a cross-talk between cancer cells and the immune system	212
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer	209
The human RNASET2 protein affects the polarization pattern of human macrophages in vitro	209
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	208
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	207
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	206
Analysis of Graves’ disease from the origins to the recent historical evolution	205
Orchestration of angiogenesis by immune cells	203
The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cells	201
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment	201
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene	198
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.	196
Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication	196
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy	195
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors	195
Early triggering of natural killer and dendritic cell during antitumor therapeutic response induced by TNFa tumor vessel delivery and melphalan	194
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy	192
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene	191
Regulation of macrophage differentiation and polarization pattern by human RNASET2 protein	191
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells	190
CD56(bright)CD16(-) NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4(+) T Cell Proliferation	190
The story of a vitamin for bone health that upgraded to hormone for systemic good health.	187
Analysis of the antigen specific T cell repertoire in HIV infection	187
Selection of virus variants and emergence of virus escape mutants after immunization with epitope vaccine	185
Schedule-dependent therapeutic efficacy of L19mTNF-a and Melphalan combined with Gemcitabine	184
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis	184
New strategies of mammary cancer vaccination	183
Early DC and NK cell activation during anticancer therapeutic response induced by TNFa tumor vessel delivery and melphalan	183
The rnaset2 oncosuppressor protein regulates both differentiation and polarization in human macrophages	179
Tumor vasculature targeted TNFα therapy: reversion of microenvironment anergy and enhancement of the anti-tumor efficiency.	177
The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic eﬀectors	174
Biomedicine and traditional Chinese medicine: a fruitful scientific and cultural interaction.	173
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.	172
Recognition of human T Leukaemia virus (HTLV-I) envelope by human CD4+ T cell lines from HTLV-I seronegative individuals: specificity and clonal heterogeneity.	171
Natural killer cells from pleural effusions are responsive to interleukin-2 but are endowed with a potent pro-angiogenic feature	170
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment	170
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation	169
Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis	166
Type 1 CD4+ T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptide vaccine in rhesus macaques.	165
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease	165
Analyse de DC-SIGN dans un modèle de résistance au SIDA	164
Prostate cancer peripheral blood NK cells show enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 production, and secrete monocyte-recruiting and polarizing factors.	161
Plasmocytoid dendritic cell dynamics and alpha IFN production during Simian Immunodeficiency Virus infection with a nonpathogenic outcome	160
Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state.	160
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	159
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy	158
Natural killer cells infiltrating colo-rectal cancer are switched towards the decidual-like pro-angiogenic CD56brightCD16- NK cell subset	158
Down syndrome, autoimmunity and T regulatory cells	155
Prolonged temporary remission in T1DM patients is associated to a distinctive Treg phenotype	155
Analysis of a combined immunodeficiency patient with defect in MHCII expression (BLS) reveals the presence of several mutant isoforms of RFXANK mRNA	153
Pleural effusion NK cells from metastatic tumors display pro-angiogenic features and pleural effusion fluids block their response to IL-2 treatment	151
STAT3 and STAT5 drive the pro-angiogenic NK cell polarization in colorectal cancer patients	151
Tumor infiltrating (TINKs) and tumor associated (TANKs) from colorectal cancer patients are proangiogenic and express angiogenin and the MMP9-TIMP2, similar to decidual NK cells	151
Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection	151
The human RNASET2 alarmin-like molecule differentially affects prostate cancer cells behavior in both cell autonomous and non-cell autonomous manners	150
Antitumor vaccines and immunotherapeutic strategies based on CIITA-driven MHC class II espression in cancer cells.	150
Analysis of the selection pressure by the NEF-immunodominant macaque CTL response in SIV infection	149
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non-small cell lung cancer (NSCLC)	149
Early functional activation of natural killer cell and dendritic cell during the antitumor therapeutic response induced by TNFa tumor vessel delivery and melphalan	149
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota	148
CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy.	147
The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (CIITA)	147
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions	146
The oncosuppressive role of RNASET2 gene in a mouse tumor syngeneic model	146
Subcapsular sinus macrophages promote melanoma metastasis to the sentinel lymph nodes via an IL-1α-STAT3 axis	145
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y	145
CIITA-driven MHC class II expressing tumor cells of distinct hystotype act as a potent antitumor vaccine and as a superior generators of tumor-specific CD4+ T lymphocytes for immunotherapy.	145
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions	145
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis	145
When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors	145
Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes	144
The MHC class II transactivator (CIITA): a physiologic inhibitor of HIV1 and HTLV2 retroviral infections	143
Immune-mediated mechanisms in patients tested positive for SARS-CoV-2: Protocol for a multianalysis study	143
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients	143
The MHC class II transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection.	142
A new strategy of tumor vaccination based on tumor cells transduced with the MHC class II transactivator CIITA	141
Functional and phenotypic characterization of tumor infiltrating NK cells.	141
Totale	21.088

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	153.573
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	153.573

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	2.173	0	286	212	113	100	56	134	165	213	317	220	357
2022/2023	3.904	335	198	250	412	267	774	60	487	521	189	203	208
2023/2024	7.374	1.081	1.086	1.114	1.210	1.244	513	132	167	213	241	177	196
2024/2025	4.895	146	170	773	314	334	320	185	260	447	474	371	1.101
2025/2026	10.440	682	556	428	1.346	1.117	562	2.307	697	1.073	742	490	440
2026/2027	811	335	476	0	0	0	0	0	0	0	0	0	0
Totale													40.778